Showing results (211-220 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|November 3, 2025
Cost-Effectiveness of Once-Weekly Insulin Icodec versus Daily Basal Insulins in Chinese Adults with T2DM: A Treatment-Background Stratified AnalysisZeyu Xie, Weishang Deng, Zhuoru Liang, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 4, 2025
Prices of Anti-Diabetic Drugs Sold in Private Pharmacies in Côte d'Ivoire, 2023: A Secondary AnalysisAkissi Régine Attia Konan, Kouamé Koffi, Emeline Annita Hounsa Alla, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 17, 2025
Budget Impact Analysis of Botulinum Toxin Type A for Patients with Severe Blepharospasm in ThailandParima Hirunwiwatkul, Unchalee Permsuwan, Sureerat Ngamkiatphaisan, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 18, 2020
Analysis of Preferences in the Use of Fixed-Doses Combinations Antihypertensive Drugs in the Regions of Far-Eastern Federal DistrictMariia Sergeevna Soboleva, Ekaterina Efimovna Loskutova
Clinicoeconomics and Outcomes Research : CEOR|August 1, 2022
Cost-Utility Analysis of Transcatheter Aortic Valve Implantation versus Surgery in High-Risk Severe Aortic Stenosis Patients in ThailandUnchalee Permsuwan, Voratima Yoodee, Wacin Buddhari, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 25, 2021
Mask Mandates and COVID-19 Related Symptoms in the USMy Nguyen
Clinicoeconomics and Outcomes Research : CEOR|October 22, 2019
Management Of Glaucoma In Developing Countries: Challenges And Opportunities For ImprovementMaria Fernanda Delgado, Ahmed Mostafa Abdelrahman, Malika Terahi, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 19, 2016
The epidemiology and burden of Alzheimer's disease in Taiwan utilizing data from the National Health Insurance Research DatabaseYen-Ni Hung, Zbigniew Kadziola, Alan Jm Brnabic, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 19, 2016
Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancerGareth K Forde, Jenny Chang, Argyrios Ziogas
Pageof 102